nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—ATM—epilepsy syndrome	0.278	0.835	CbGaD
Caffeine—ADORA1—Gabapentin—epilepsy syndrome	0.0511	0.122	CbGbCtD
Caffeine—CYP2D6—epilepsy syndrome	0.0322	0.0966	CbGaD
Caffeine—ABCB1—epilepsy syndrome	0.023	0.0689	CbGaD
Caffeine—CYP1B1—Propofol—epilepsy syndrome	0.017	0.0408	CbGbCtD
Caffeine—CYP1B1—Phenobarbital—epilepsy syndrome	0.0163	0.0389	CbGbCtD
Caffeine—CYP2E1—Felbamate—epilepsy syndrome	0.0102	0.0244	CbGbCtD
Caffeine—CYP2E1—Trimethadione—epilepsy syndrome	0.0102	0.0244	CbGbCtD
Caffeine—CYP2E1—Clonazepam—epilepsy syndrome	0.00868	0.0208	CbGbCtD
Caffeine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00854	0.0204	CbGbCtD
Caffeine—CYP2C8—Trimethadione—epilepsy syndrome	0.00763	0.0183	CbGbCtD
Caffeine—CYP1A1—Propofol—epilepsy syndrome	0.00747	0.0179	CbGbCtD
Caffeine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00717	0.0172	CbGbCtD
Caffeine—CYP3A7—Carbamazepine—epilepsy syndrome	0.00715	0.0171	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00715	0.0171	CbGbCtD
Caffeine—CYP1A1—Phenobarbital—epilepsy syndrome	0.00714	0.0171	CbGbCtD
Caffeine—CYP2E1—Rufinamide—epilepsy syndrome	0.00708	0.0169	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00641	0.0153	CbGbCtD
Caffeine—CYP3A7—Phenytoin—epilepsy syndrome	0.00641	0.0153	CbGbCtD
Caffeine—ABCB1—Levetiracetam—epilepsy syndrome	0.00607	0.0145	CbGbCtD
Caffeine—CYP2E1—Propofol—epilepsy syndrome	0.00577	0.0138	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00571	0.0137	CbGbCtD
Caffeine—CYP3A7—Phenobarbital—epilepsy syndrome	0.00571	0.0137	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00563	0.0135	CbGbCtD
Caffeine—CYP3A7—Midazolam—epilepsy syndrome	0.00563	0.0135	CbGbCtD
Caffeine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00551	0.0132	CbGbCtD
Caffeine—CYP2E1—Midazolam—epilepsy syndrome	0.00544	0.013	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00541	0.013	CbGbCtD
Caffeine—CYP3A7—Diazepam—epilepsy syndrome	0.00541	0.013	CbGbCtD
Caffeine—CYP3A5—Carbamazepine—epilepsy syndrome	0.00536	0.0128	CbGbCtD
Caffeine—CYP2C9—Trimethadione—epilepsy syndrome	0.00532	0.0127	CbGbCtD
Caffeine—CYP2E1—Diazepam—epilepsy syndrome	0.00523	0.0125	CbGbCtD
Caffeine—CYP2C8—Carbamazepine—epilepsy syndrome	0.00515	0.0123	CbGbCtD
Caffeine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.005	0.012	CbGbCtD
Caffeine—CYP2C8—Primidone—epilepsy syndrome	0.00481	0.0115	CbGbCtD
Caffeine—CYP3A5—Phenytoin—epilepsy syndrome	0.00481	0.0115	CbGbCtD
Caffeine—CYP2C8—Phenytoin—epilepsy syndrome	0.00462	0.0111	CbGbCtD
Caffeine—CYP2C8—Propofol—epilepsy syndrome	0.00431	0.0103	CbGbCtD
Caffeine—CYP3A5—Phenobarbital—epilepsy syndrome	0.00428	0.0103	CbGbCtD
Caffeine—CYP3A5—Midazolam—epilepsy syndrome	0.00423	0.0101	CbGbCtD
Caffeine—ABCB1—Clobazam—epilepsy syndrome	0.00421	0.0101	CbGbCtD
Caffeine—CYP2C8—Phenobarbital—epilepsy syndrome	0.00412	0.00986	CbGbCtD
Caffeine—CYP3A5—Diazepam—epilepsy syndrome	0.00406	0.00972	CbGbCtD
Caffeine—ABCB1—Lamotrigine—epilepsy syndrome	0.00405	0.0097	CbGbCtD
Caffeine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00399	0.00955	CbGbCtD
Caffeine—CYP2C8—Diazepam—epilepsy syndrome	0.00391	0.00935	CbGbCtD
Caffeine—CYP1A2—Primidone—epilepsy syndrome	0.00372	0.00892	CbGbCtD
Caffeine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00359	0.00861	CbGbCtD
Caffeine—ABCB1—Carbamazepine—epilepsy syndrome	0.00349	0.00835	CbGbCtD
Caffeine—CYP2C9—Primidone—epilepsy syndrome	0.00336	0.00803	CbGbCtD
Caffeine—CYP1A2—Propofol—epilepsy syndrome	0.00334	0.00799	CbGbCtD
Caffeine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00333	0.00797	CbGbCtD
Caffeine—CYP2C9—Phenytoin—epilepsy syndrome	0.00322	0.00772	CbGbCtD
Caffeine—CYP3A5—Valproic Acid—epilepsy syndrome	0.0032	0.00767	CbGbCtD
Caffeine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00319	0.00764	CbGbCtD
Caffeine—ABCB1—Phenytoin—epilepsy syndrome	0.00313	0.00749	CbGbCtD
Caffeine—CYP3A4—Felbamate—epilepsy syndrome	0.00309	0.00741	CbGbCtD
Caffeine—CYP3A4—Trimethadione—epilepsy syndrome	0.00309	0.00741	CbGbCtD
Caffeine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00308	0.00737	CbGbCtD
Caffeine—CYP1A2—Diazepam—epilepsy syndrome	0.00302	0.00724	CbGbCtD
Caffeine—CYP2C9—Propofol—epilepsy syndrome	0.00301	0.0072	CbGbCtD
Caffeine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00291	0.00696	CbGbCtD
Caffeine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00287	0.00688	CbGbCtD
Caffeine—ABCB1—Phenobarbital—epilepsy syndrome	0.00279	0.00668	CbGbCtD
Caffeine—ABCB1—Midazolam—epilepsy syndrome	0.00275	0.00658	CbGbCtD
Caffeine—CYP2D6—Propofol—epilepsy syndrome	0.00275	0.00658	CbGbCtD
Caffeine—CYP2C9—Diazepam—epilepsy syndrome	0.00272	0.00652	CbGbCtD
Caffeine—ABCB1—Diazepam—epilepsy syndrome	0.00264	0.00633	CbGbCtD
Caffeine—CYP3A4—Clonazepam—epilepsy syndrome	0.00263	0.0063	CbGbCtD
Caffeine—CYP3A4—Clobazam—epilepsy syndrome	0.00252	0.00604	CbGbCtD
Caffeine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00238	0.00571	CbGbCtD
Caffeine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00215	0.00514	CbGbCtD
Caffeine—CYP3A4—Rufinamide—epilepsy syndrome	0.00214	0.00513	CbGbCtD
Caffeine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00209	0.005	CbGbCtD
Caffeine—Pentoxifylline—NT5E—epilepsy syndrome	0.002	0.952	CrCbGaD
Caffeine—CYP3A4—Primidone—epilepsy syndrome	0.00195	0.00467	CbGbCtD
Caffeine—CYP3A4—Phenytoin—epilepsy syndrome	0.00187	0.00449	CbGbCtD
Caffeine—ATM—hindbrain—epilepsy syndrome	0.00179	0.0385	CbGeAlD
Caffeine—CYP3A4—Propofol—epilepsy syndrome	0.00175	0.00419	CbGbCtD
Caffeine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00167	0.004	CbGbCtD
Caffeine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00167	0.004	CbGbCtD
Caffeine—CYP3A4—Midazolam—epilepsy syndrome	0.00165	0.00394	CbGbCtD
Caffeine—CYP3A4—Diazepam—epilepsy syndrome	0.00158	0.00379	CbGbCtD
Caffeine—CYP3A4—Zonisamide—epilepsy syndrome	0.00155	0.0037	CbGbCtD
Caffeine—PIK3CB—hindbrain—epilepsy syndrome	0.00138	0.0298	CbGeAlD
Caffeine—PIK3CA—hindbrain—epilepsy syndrome	0.00137	0.0295	CbGeAlD
Caffeine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00125	0.00299	CbGbCtD
Caffeine—CYP3A4—Topiramate—epilepsy syndrome	0.00113	0.0027	CbGbCtD
Caffeine—ADORA2A—ganglion—epilepsy syndrome	0.00111	0.0238	CbGeAlD
Caffeine—ATM—brainstem—epilepsy syndrome	0.00103	0.0221	CbGeAlD
Caffeine—ADORA1—ganglion—epilepsy syndrome	0.000955	0.0205	CbGeAlD
Caffeine—ATM—telencephalon—epilepsy syndrome	0.000911	0.0196	CbGeAlD
Caffeine—PIK3CD—forebrain—epilepsy syndrome	0.000878	0.0189	CbGeAlD
Caffeine—PRKDC—telencephalon—epilepsy syndrome	0.000861	0.0185	CbGeAlD
Caffeine—PIK3CD—telencephalon—epilepsy syndrome	0.000808	0.0174	CbGeAlD
Caffeine—PIK3CB—brainstem—epilepsy syndrome	0.000794	0.0171	CbGeAlD
Caffeine—PIK3CA—brainstem—epilepsy syndrome	0.000786	0.0169	CbGeAlD
Caffeine—PIK3CB—forebrain—epilepsy syndrome	0.000766	0.0165	CbGeAlD
Caffeine—PIK3CA—forebrain—epilepsy syndrome	0.000758	0.0163	CbGeAlD
Caffeine—PIK3CB—telencephalon—epilepsy syndrome	0.000704	0.0151	CbGeAlD
Caffeine—PIK3CA—telencephalon—epilepsy syndrome	0.000697	0.015	CbGeAlD
Caffeine—PRKDC—medulla oblongata—epilepsy syndrome	0.000677	0.0145	CbGeAlD
Caffeine—PIK3CD—medulla oblongata—epilepsy syndrome	0.000635	0.0136	CbGeAlD
Caffeine—PRKDC—midbrain—epilepsy syndrome	0.000618	0.0133	CbGeAlD
Caffeine—PRKDC—spinal cord—epilepsy syndrome	0.000603	0.013	CbGeAlD
Caffeine—ATM—head—epilepsy syndrome	0.000567	0.0122	CbGeAlD
Caffeine—PIK3CD—spinal cord—epilepsy syndrome	0.000566	0.0122	CbGeAlD
Caffeine—PIK3CB—medulla oblongata—epilepsy syndrome	0.000554	0.0119	CbGeAlD
Caffeine—RYR1—medulla oblongata—epilepsy syndrome	0.000548	0.0118	CbGeAlD
Caffeine—PIK3CA—medulla oblongata—epilepsy syndrome	0.000548	0.0118	CbGeAlD
Caffeine—ATM—nervous system—epilepsy syndrome	0.000538	0.0116	CbGeAlD
Caffeine—ATM—central nervous system—epilepsy syndrome	0.000518	0.0111	CbGeAlD
Caffeine—ATM—cerebellum—epilepsy syndrome	0.000506	0.0109	CbGeAlD
Caffeine—PIK3CB—midbrain—epilepsy syndrome	0.000506	0.0109	CbGeAlD
Caffeine—PIK3CD—head—epilepsy syndrome	0.000503	0.0108	CbGeAlD
Caffeine—RYR1—midbrain—epilepsy syndrome	0.000501	0.0108	CbGeAlD
Caffeine—PIK3CA—midbrain—epilepsy syndrome	0.000501	0.0108	CbGeAlD
Caffeine—PIK3CB—spinal cord—epilepsy syndrome	0.000494	0.0106	CbGeAlD
Caffeine—PIK3CA—spinal cord—epilepsy syndrome	0.000488	0.0105	CbGeAlD
Caffeine—PRKDC—cerebellum—epilepsy syndrome	0.000478	0.0103	CbGeAlD
Caffeine—PIK3CD—nervous system—epilepsy syndrome	0.000477	0.0102	CbGeAlD
Caffeine—ADORA2A—forebrain—epilepsy syndrome	0.000464	0.00998	CbGeAlD
Caffeine—PIK3CD—central nervous system—epilepsy syndrome	0.000459	0.00987	CbGeAlD
Caffeine—PIK3CD—cerebellum—epilepsy syndrome	0.000449	0.00964	CbGeAlD
Caffeine—PIK3CB—head—epilepsy syndrome	0.000439	0.00943	CbGeAlD
Caffeine—RYR1—head—epilepsy syndrome	0.000434	0.00933	CbGeAlD
Caffeine—PIK3CA—head—epilepsy syndrome	0.000434	0.00933	CbGeAlD
Caffeine—ADORA2A—telencephalon—epilepsy syndrome	0.000427	0.00917	CbGeAlD
Caffeine—PIK3CB—nervous system—epilepsy syndrome	0.000416	0.00894	CbGeAlD
Caffeine—RYR1—nervous system—epilepsy syndrome	0.000412	0.00885	CbGeAlD
Caffeine—PIK3CA—nervous system—epilepsy syndrome	0.000412	0.00885	CbGeAlD
Caffeine—ATM—brain—epilepsy syndrome	0.000411	0.00883	CbGeAlD
Caffeine—ADORA1—forebrain—epilepsy syndrome	0.000401	0.00861	CbGeAlD
Caffeine—PIK3CB—central nervous system—epilepsy syndrome	0.0004	0.00861	CbGeAlD
Caffeine—RYR1—central nervous system—epilepsy syndrome	0.000396	0.00852	CbGeAlD
Caffeine—PIK3CA—central nervous system—epilepsy syndrome	0.000396	0.00852	CbGeAlD
Caffeine—PIK3CB—cerebellum—epilepsy syndrome	0.000391	0.00841	CbGeAlD
Caffeine—PRKDC—brain—epilepsy syndrome	0.000389	0.00835	CbGeAlD
Caffeine—RYR1—cerebellum—epilepsy syndrome	0.000387	0.00833	CbGeAlD
Caffeine—PIK3CA—cerebellum—epilepsy syndrome	0.000387	0.00833	CbGeAlD
Caffeine—ADORA1—telencephalon—epilepsy syndrome	0.000369	0.00792	CbGeAlD
Caffeine—PIK3CD—brain—epilepsy syndrome	0.000364	0.00783	CbGeAlD
Caffeine—ADORA2B—head—epilepsy syndrome	0.000319	0.00687	CbGeAlD
Caffeine—PIK3CB—brain—epilepsy syndrome	0.000318	0.00683	CbGeAlD
Caffeine—RYR1—brain—epilepsy syndrome	0.000315	0.00676	CbGeAlD
Caffeine—PIK3CA—brain—epilepsy syndrome	0.000315	0.00676	CbGeAlD
Caffeine—ADORA2B—nervous system—epilepsy syndrome	0.000303	0.00651	CbGeAlD
Caffeine—ADORA2A—spinal cord—epilepsy syndrome	0.000299	0.00643	CbGeAlD
Caffeine—PDE4B—forebrain—epilepsy syndrome	0.000296	0.00637	CbGeAlD
Caffeine—ADORA2B—central nervous system—epilepsy syndrome	0.000292	0.00627	CbGeAlD
Caffeine—ADORA1—medulla oblongata—epilepsy syndrome	0.00029	0.00622	CbGeAlD
Caffeine—ADORA2B—cerebellum—epilepsy syndrome	0.000285	0.00613	CbGeAlD
Caffeine—PDE4B—telencephalon—epilepsy syndrome	0.000273	0.00586	CbGeAlD
Caffeine—ADORA2A—head—epilepsy syndrome	0.000266	0.00571	CbGeAlD
Caffeine—ADORA1—midbrain—epilepsy syndrome	0.000265	0.00569	CbGeAlD
Caffeine—ADORA1—spinal cord—epilepsy syndrome	0.000258	0.00555	CbGeAlD
Caffeine—ADORA2A—nervous system—epilepsy syndrome	0.000252	0.00542	CbGeAlD
Caffeine—ADORA2A—central nervous system—epilepsy syndrome	0.000243	0.00521	CbGeAlD
Caffeine—ADORA2A—cerebellum—epilepsy syndrome	0.000237	0.0051	CbGeAlD
Caffeine—CYP2D6—hindbrain—epilepsy syndrome	0.000234	0.00504	CbGeAlD
Caffeine—CYP1B1—telencephalon—epilepsy syndrome	0.000234	0.00502	CbGeAlD
Caffeine—ADORA2B—brain—epilepsy syndrome	0.000231	0.00498	CbGeAlD
Caffeine—ADORA1—head—epilepsy syndrome	0.000229	0.00493	CbGeAlD
Caffeine—ADORA1—nervous system—epilepsy syndrome	0.000218	0.00468	CbGeAlD
Caffeine—PDE4B—medulla oblongata—epilepsy syndrome	0.000214	0.0046	CbGeAlD
Caffeine—ADORA1—central nervous system—epilepsy syndrome	0.000209	0.0045	CbGeAlD
Caffeine—ADORA1—cerebellum—epilepsy syndrome	0.000205	0.0044	CbGeAlD
Caffeine—PDE4B—midbrain—epilepsy syndrome	0.000196	0.00421	CbGeAlD
Caffeine—ADORA2A—brain—epilepsy syndrome	0.000193	0.00414	CbGeAlD
Caffeine—PDE4B—spinal cord—epilepsy syndrome	0.000191	0.00411	CbGeAlD
Caffeine—PDE4B—head—epilepsy syndrome	0.00017	0.00365	CbGeAlD
Caffeine—ADORA1—brain—epilepsy syndrome	0.000166	0.00357	CbGeAlD
Caffeine—Urine output increased—Topiramate—epilepsy syndrome	0.000161	0.00179	CcSEcCtD
Caffeine—Agitation—Fosphenytoin—epilepsy syndrome	0.000161	0.00178	CcSEcCtD
Caffeine—PDE4B—nervous system—epilepsy syndrome	0.000161	0.00346	CbGeAlD
Caffeine—Irritability—Pregabalin—epilepsy syndrome	0.00016	0.00177	CcSEcCtD
Caffeine—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.00016	0.00177	CcSEcCtD
Caffeine—Immune system disorder—Clonazepam—epilepsy syndrome	0.000159	0.00176	CcSEcCtD
Caffeine—Malnutrition—Zonisamide—epilepsy syndrome	0.000159	0.00176	CcSEcCtD
Caffeine—Immune system disorder—Phenytoin—epilepsy syndrome	0.000158	0.00175	CcSEcCtD
Caffeine—Nervousness—Felbamate—epilepsy syndrome	0.000158	0.00175	CcSEcCtD
Caffeine—Hypoglycaemia—Gabapentin—epilepsy syndrome	0.000158	0.00175	CcSEcCtD
Caffeine—Immune system disorder—Oxcarbazepine—epilepsy syndrome	0.000157	0.00174	CcSEcCtD
Caffeine—Convulsion—Levetiracetam—epilepsy syndrome	0.000157	0.00174	CcSEcCtD
Caffeine—Blood creatinine increased—Pregabalin—epilepsy syndrome	0.000157	0.00174	CcSEcCtD
Caffeine—Agitation—Vigabatrin—epilepsy syndrome	0.000157	0.00174	CcSEcCtD
Caffeine—Cardiac disorder—Carbamazepine—epilepsy syndrome	0.000155	0.00172	CcSEcCtD
Caffeine—PDE4B—central nervous system—epilepsy syndrome	0.000155	0.00333	CbGeAlD
Caffeine—Nervousness—Zonisamide—epilepsy syndrome	0.000155	0.00171	CcSEcCtD
Caffeine—Agitation—Diazepam—epilepsy syndrome	0.000154	0.00171	CcSEcCtD
Caffeine—Dry skin—Pregabalin—epilepsy syndrome	0.000154	0.0017	CcSEcCtD
Caffeine—Malnutrition—Clonazepam—epilepsy syndrome	0.000153	0.0017	CcSEcCtD
Caffeine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000152	0.00169	CcSEcCtD
Caffeine—Convulsion—Fosphenytoin—epilepsy syndrome	0.000152	0.00168	CcSEcCtD
Caffeine—Malnutrition—Oxcarbazepine—epilepsy syndrome	0.000152	0.00168	CcSEcCtD
Caffeine—PDE4B—cerebellum—epilepsy syndrome	0.000151	0.00326	CbGeAlD
Caffeine—Hypertension—Fosphenytoin—epilepsy syndrome	0.000151	0.00168	CcSEcCtD
Caffeine—Immune system disorder—Carbamazepine—epilepsy syndrome	0.000151	0.00167	CcSEcCtD
Caffeine—CYP2E1—telencephalon—epilepsy syndrome	0.000151	0.00324	CbGeAlD
Caffeine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.00015	0.00166	CcSEcCtD
Caffeine—Tachycardia—Propofol—epilepsy syndrome	0.00015	0.00166	CcSEcCtD
Caffeine—Agitation—Felbamate—epilepsy syndrome	0.000149	0.00166	CcSEcCtD
Caffeine—Nervousness—Clonazepam—epilepsy syndrome	0.000149	0.00165	CcSEcCtD
Caffeine—Gastritis—Pregabalin—epilepsy syndrome	0.000148	0.00165	CcSEcCtD
Caffeine—Nervousness—Phenytoin—epilepsy syndrome	0.000148	0.00164	CcSEcCtD
Caffeine—Convulsion—Vigabatrin—epilepsy syndrome	0.000148	0.00164	CcSEcCtD
Caffeine—Rash—Trimethadione—epilepsy syndrome	0.000147	0.00163	CcSEcCtD
Caffeine—Nervousness—Oxcarbazepine—epilepsy syndrome	0.000147	0.00163	CcSEcCtD
Caffeine—Dermatitis—Trimethadione—epilepsy syndrome	0.000147	0.00163	CcSEcCtD
Caffeine—Infection—Levetiracetam—epilepsy syndrome	0.000147	0.00163	CcSEcCtD
Caffeine—Nervous system disorder—Midazolam—epilepsy syndrome	0.000147	0.00163	CcSEcCtD
Caffeine—Irritability—Gabapentin—epilepsy syndrome	0.000147	0.00163	CcSEcCtD
Caffeine—Tachycardia—Midazolam—epilepsy syndrome	0.000146	0.00162	CcSEcCtD
Caffeine—Agitation—Zonisamide—epilepsy syndrome	0.000146	0.00162	CcSEcCtD
Caffeine—Skin disorder—Midazolam—epilepsy syndrome	0.000146	0.00161	CcSEcCtD
Caffeine—Malnutrition—Carbamazepine—epilepsy syndrome	0.000145	0.00161	CcSEcCtD
Caffeine—CYP1B1—head—epilepsy syndrome	0.000145	0.00313	CbGeAlD
Caffeine—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000145	0.00161	CcSEcCtD
Caffeine—Deafness—Topiramate—epilepsy syndrome	0.000145	0.0016	CcSEcCtD
Caffeine—Blood creatinine increased—Gabapentin—epilepsy syndrome	0.000144	0.0016	CcSEcCtD
Caffeine—Skin disorder—Levetiracetam—epilepsy syndrome	0.000144	0.00159	CcSEcCtD
Caffeine—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000142	0.00158	CcSEcCtD
Caffeine—Infection—Fosphenytoin—epilepsy syndrome	0.000142	0.00157	CcSEcCtD
Caffeine—Nervousness—Carbamazepine—epilepsy syndrome	0.000141	0.00157	CcSEcCtD
Caffeine—Agitation—Clonazepam—epilepsy syndrome	0.000141	0.00156	CcSEcCtD
Caffeine—Dry skin—Gabapentin—epilepsy syndrome	0.000141	0.00156	CcSEcCtD
Caffeine—Malnutrition—Lamotrigine—epilepsy syndrome	0.000141	0.00156	CcSEcCtD
Caffeine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000141	0.00156	CcSEcCtD
Caffeine—Hypertension—Felbamate—epilepsy syndrome	0.00014	0.00156	CcSEcCtD
Caffeine—Agitation—Phenytoin—epilepsy syndrome	0.00014	0.00155	CcSEcCtD
Caffeine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000139	0.00155	CcSEcCtD
Caffeine—Agitation—Oxcarbazepine—epilepsy syndrome	0.000139	0.00154	CcSEcCtD
Caffeine—Infection—Vigabatrin—epilepsy syndrome	0.000138	0.00153	CcSEcCtD
Caffeine—Convulsion—Zonisamide—epilepsy syndrome	0.000138	0.00153	CcSEcCtD
Caffeine—CYP1B1—nervous system—epilepsy syndrome	0.000138	0.00296	CbGeAlD
Caffeine—Hypertension—Zonisamide—epilepsy syndrome	0.000137	0.00152	CcSEcCtD
Caffeine—Dyspnoea—Propofol—epilepsy syndrome	0.000137	0.00151	CcSEcCtD
Caffeine—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000137	0.00151	CcSEcCtD
Caffeine—Nervousness—Lamotrigine—epilepsy syndrome	0.000137	0.00151	CcSEcCtD
Caffeine—Infection—Diazepam—epilepsy syndrome	0.000136	0.00151	CcSEcCtD
Caffeine—Gastritis—Gabapentin—epilepsy syndrome	0.000136	0.00151	CcSEcCtD
Caffeine—Skin disorder—Vigabatrin—epilepsy syndrome	0.000135	0.0015	CcSEcCtD
Caffeine—Nervous system disorder—Diazepam—epilepsy syndrome	0.000135	0.00149	CcSEcCtD
Caffeine—CYP2D6—brainstem—epilepsy syndrome	0.000134	0.00289	CbGeAlD
Caffeine—Tachycardia—Diazepam—epilepsy syndrome	0.000134	0.00148	CcSEcCtD
Caffeine—Agitation—Carbamazepine—epilepsy syndrome	0.000134	0.00148	CcSEcCtD
Caffeine—Dyspnoea—Midazolam—epilepsy syndrome	0.000134	0.00148	CcSEcCtD
Caffeine—Skin disorder—Diazepam—epilepsy syndrome	0.000133	0.00148	CcSEcCtD
Caffeine—CYP1B1—central nervous system—epilepsy syndrome	0.000133	0.00285	CbGeAlD
Caffeine—Hypoglycaemia—Topiramate—epilepsy syndrome	0.000133	0.00147	CcSEcCtD
Caffeine—Convulsion—Phenytoin—epilepsy syndrome	0.000132	0.00146	CcSEcCtD
Caffeine—Infection—Felbamate—epilepsy syndrome	0.000132	0.00146	CcSEcCtD
Caffeine—Hypertension—Phenytoin—epilepsy syndrome	0.000132	0.00146	CcSEcCtD
Caffeine—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000131	0.00146	CcSEcCtD
Caffeine—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000131	0.00145	CcSEcCtD
Caffeine—Hyperglycaemia—Pregabalin—epilepsy syndrome	0.000131	0.00145	CcSEcCtD
Caffeine—Rash—Phenobarbital—epilepsy syndrome	0.000131	0.00145	CcSEcCtD
Caffeine—Dermatitis—Phenobarbital—epilepsy syndrome	0.00013	0.00145	CcSEcCtD
Caffeine—CYP1B1—cerebellum—epilepsy syndrome	0.00013	0.00279	CbGeAlD
Caffeine—CYP2D6—forebrain—epilepsy syndrome	0.00013	0.00279	CbGeAlD
Caffeine—Tachycardia—Felbamate—epilepsy syndrome	0.00013	0.00144	CcSEcCtD
Caffeine—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000129	0.00144	CcSEcCtD
Caffeine—Infestation NOS—Pregabalin—epilepsy syndrome	0.000129	0.00143	CcSEcCtD
Caffeine—Infestation—Pregabalin—epilepsy syndrome	0.000129	0.00143	CcSEcCtD
Caffeine—Agitation—Lamotrigine—epilepsy syndrome	0.000129	0.00143	CcSEcCtD
Caffeine—Infection—Zonisamide—epilepsy syndrome	0.000129	0.00143	CcSEcCtD
Caffeine—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000129	0.00143	CcSEcCtD
Caffeine—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000128	0.00142	CcSEcCtD
Caffeine—Rash—Rufinamide—epilepsy syndrome	0.000128	0.00142	CcSEcCtD
Caffeine—Dermatitis—Rufinamide—epilepsy syndrome	0.000128	0.00142	CcSEcCtD
Caffeine—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000128	0.00142	CcSEcCtD
Caffeine—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000127	0.00141	CcSEcCtD
Caffeine—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000127	0.00141	CcSEcCtD
Caffeine—Renal failure—Pregabalin—epilepsy syndrome	0.000127	0.00141	CcSEcCtD
Caffeine—Tachycardia—Zonisamide—epilepsy syndrome	0.000127	0.00141	CcSEcCtD
Caffeine—Skin disorder—Zonisamide—epilepsy syndrome	0.000126	0.0014	CcSEcCtD
Caffeine—Convulsion—Carbamazepine—epilepsy syndrome	0.000126	0.0014	CcSEcCtD
Caffeine—Hypertension—Carbamazepine—epilepsy syndrome	0.000126	0.00139	CcSEcCtD
Caffeine—Infection—Clonazepam—epilepsy syndrome	0.000124	0.00138	CcSEcCtD
Caffeine—Infection—Phenytoin—epilepsy syndrome	0.000124	0.00137	CcSEcCtD
Caffeine—Irritability—Topiramate—epilepsy syndrome	0.000124	0.00137	CcSEcCtD
Caffeine—PDE4B—brain—epilepsy syndrome	0.000123	0.00264	CbGeAlD
Caffeine—Infection—Oxcarbazepine—epilepsy syndrome	0.000123	0.00136	CcSEcCtD
Caffeine—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000123	0.00136	CcSEcCtD
Caffeine—Dyspnoea—Diazepam—epilepsy syndrome	0.000122	0.00136	CcSEcCtD
Caffeine—Tachycardia—Clonazepam—epilepsy syndrome	0.000122	0.00135	CcSEcCtD
Caffeine—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000122	0.00135	CcSEcCtD
Caffeine—Convulsion—Lamotrigine—epilepsy syndrome	0.000122	0.00135	CcSEcCtD
Caffeine—Skin disorder—Clonazepam—epilepsy syndrome	0.000122	0.00135	CcSEcCtD
Caffeine—Tachycardia—Phenytoin—epilepsy syndrome	0.000121	0.00135	CcSEcCtD
Caffeine—Hypertension—Lamotrigine—epilepsy syndrome	0.000121	0.00135	CcSEcCtD
Caffeine—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000121	0.00135	CcSEcCtD
Caffeine—Blood creatinine increased—Topiramate—epilepsy syndrome	0.000121	0.00134	CcSEcCtD
Caffeine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000121	0.00134	CcSEcCtD
Caffeine—Rash—Lacosamide—epilepsy syndrome	0.00012	0.00133	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.00012	0.00133	CcSEcCtD
Caffeine—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.00012	0.00133	CcSEcCtD
Caffeine—Dermatitis—Lacosamide—epilepsy syndrome	0.00012	0.00133	CcSEcCtD
Caffeine—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.00012	0.00133	CcSEcCtD
Caffeine—CYP2D6—telencephalon—epilepsy syndrome	0.000119	0.00256	CbGeAlD
Caffeine—Infestation NOS—Gabapentin—epilepsy syndrome	0.000119	0.00131	CcSEcCtD
Caffeine—Infestation—Gabapentin—epilepsy syndrome	0.000119	0.00131	CcSEcCtD
Caffeine—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000118	0.00131	CcSEcCtD
Caffeine—Dyspnoea—Felbamate—epilepsy syndrome	0.000118	0.00131	CcSEcCtD
Caffeine—CYP2E1—medulla oblongata—epilepsy syndrome	0.000118	0.00254	CbGeAlD
Caffeine—Infection—Carbamazepine—epilepsy syndrome	0.000118	0.00131	CcSEcCtD
Caffeine—Rash—Clobazam—epilepsy syndrome	0.000117	0.00129	CcSEcCtD
Caffeine—Dermatitis—Clobazam—epilepsy syndrome	0.000117	0.00129	CcSEcCtD
Caffeine—Haemoglobin—Pregabalin—epilepsy syndrome	0.000117	0.00129	CcSEcCtD
Caffeine—Renal failure—Gabapentin—epilepsy syndrome	0.000117	0.00129	CcSEcCtD
Caffeine—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000116	0.00129	CcSEcCtD
Caffeine—Haemorrhage—Pregabalin—epilepsy syndrome	0.000116	0.00129	CcSEcCtD
Caffeine—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000116	0.00129	CcSEcCtD
Caffeine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000116	0.00128	CcSEcCtD
Caffeine—Dyspnoea—Zonisamide—epilepsy syndrome	0.000116	0.00128	CcSEcCtD
Caffeine—Skin disorder—Carbamazepine—epilepsy syndrome	0.000115	0.00128	CcSEcCtD
Caffeine—Gastritis—Topiramate—epilepsy syndrome	0.000115	0.00127	CcSEcCtD
Caffeine—Infection—Lamotrigine—epilepsy syndrome	0.000114	0.00126	CcSEcCtD
Caffeine—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000113	0.00125	CcSEcCtD
Caffeine—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000112	0.00124	CcSEcCtD
Caffeine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000112	0.00124	CcSEcCtD
Caffeine—Malnutrition—Valproic Acid—epilepsy syndrome	0.000112	0.00124	CcSEcCtD
Caffeine—Dyspnoea—Clonazepam—epilepsy syndrome	0.000112	0.00124	CcSEcCtD
Caffeine—Dyspnoea—Phenytoin—epilepsy syndrome	0.000111	0.00123	CcSEcCtD
Caffeine—Hypersensitivity—Midazolam—epilepsy syndrome	0.00011	0.00122	CcSEcCtD
Caffeine—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.00011	0.00122	CcSEcCtD
Caffeine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000109	0.00121	CcSEcCtD
Caffeine—Nervousness—Valproic Acid—epilepsy syndrome	0.000109	0.0012	CcSEcCtD
Caffeine—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000108	0.0012	CcSEcCtD
Caffeine—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000108	0.00119	CcSEcCtD
Caffeine—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000107	0.00119	CcSEcCtD
Caffeine—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000107	0.00118	CcSEcCtD
Caffeine—Haemorrhage—Gabapentin—epilepsy syndrome	0.000106	0.00118	CcSEcCtD
Caffeine—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000106	0.00117	CcSEcCtD
Caffeine—CYP2E1—spinal cord—epilepsy syndrome	0.000106	0.00227	CbGeAlD
Caffeine—CYP1B1—brain—epilepsy syndrome	0.000105	0.00227	CbGeAlD
Caffeine—Immune system disorder—Pregabalin—epilepsy syndrome	0.000105	0.00116	CcSEcCtD
Caffeine—CYP1A1—head—epilepsy syndrome	0.000103	0.00221	CbGeAlD
Caffeine—Agitation—Valproic Acid—epilepsy syndrome	0.000103	0.00114	CcSEcCtD
Caffeine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000103	0.00114	CcSEcCtD
Caffeine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000103	0.00114	CcSEcCtD
Caffeine—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000102	0.00113	CcSEcCtD
Caffeine—Theophylline—CYP2D6—epilepsy syndrome	0.000101	0.0482	CrCbGaD
Caffeine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000101	0.00112	CcSEcCtD
Caffeine—Malnutrition—Pregabalin—epilepsy syndrome	0.000101	0.00112	CcSEcCtD
Caffeine—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000101	0.00112	CcSEcCtD
Caffeine—Infestation—Topiramate—epilepsy syndrome	9.97e-05	0.00111	CcSEcCtD
Caffeine—Infestation NOS—Topiramate—epilepsy syndrome	9.97e-05	0.00111	CcSEcCtD
Caffeine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	9.91e-05	0.0011	CcSEcCtD
Caffeine—Cardiac disorder—Gabapentin—epilepsy syndrome	9.88e-05	0.00109	CcSEcCtD
Caffeine—Nervousness—Pregabalin—epilepsy syndrome	9.81e-05	0.00109	CcSEcCtD
Caffeine—Renal failure—Topiramate—epilepsy syndrome	9.8e-05	0.00109	CcSEcCtD
Caffeine—CYP1A1—nervous system—epilepsy syndrome	9.75e-05	0.0021	CbGeAlD
Caffeine—Rash—Propofol—epilepsy syndrome	9.66e-05	0.00107	CcSEcCtD
Caffeine—Dermatitis—Propofol—epilepsy syndrome	9.66e-05	0.00107	CcSEcCtD
Caffeine—Hypertension—Valproic Acid—epilepsy syndrome	9.65e-05	0.00107	CcSEcCtD
Caffeine—Immune system disorder—Gabapentin—epilepsy syndrome	9.61e-05	0.00107	CcSEcCtD
Caffeine—Hypersensitivity—Zonisamide—epilepsy syndrome	9.57e-05	0.00106	CcSEcCtD
Caffeine—Rash—Midazolam—epilepsy syndrome	9.46e-05	0.00105	CcSEcCtD
Caffeine—Dermatitis—Midazolam—epilepsy syndrome	9.45e-05	0.00105	CcSEcCtD
Caffeine—CYP1A1—central nervous system—epilepsy syndrome	9.39e-05	0.00202	CbGeAlD
Caffeine—CYP2E1—head—epilepsy syndrome	9.38e-05	0.00202	CbGeAlD
Caffeine—Rash—Levetiracetam—epilepsy syndrome	9.34e-05	0.00104	CcSEcCtD
Caffeine—ABCB1—forebrain—epilepsy syndrome	9.33e-05	0.00201	CbGeAlD
Caffeine—Dermatitis—Levetiracetam—epilepsy syndrome	9.33e-05	0.00103	CcSEcCtD
Caffeine—Agitation—Pregabalin—epilepsy syndrome	9.28e-05	0.00103	CcSEcCtD
Caffeine—Malnutrition—Gabapentin—epilepsy syndrome	9.26e-05	0.00103	CcSEcCtD
Caffeine—Hypersensitivity—Clonazepam—epilepsy syndrome	9.23e-05	0.00102	CcSEcCtD
Caffeine—Hypersensitivity—Phenytoin—epilepsy syndrome	9.16e-05	0.00102	CcSEcCtD
Caffeine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.12e-05	0.00101	CcSEcCtD
Caffeine—Infection—Valproic Acid—epilepsy syndrome	9.06e-05	0.001	CcSEcCtD
Caffeine—Rash—Fosphenytoin—epilepsy syndrome	9.01e-05	0.000999	CcSEcCtD
Caffeine—Dermatitis—Fosphenytoin—epilepsy syndrome	9e-05	0.000998	CcSEcCtD
Caffeine—Haemoglobin—Topiramate—epilepsy syndrome	9e-05	0.000997	CcSEcCtD
Caffeine—Nervousness—Gabapentin—epilepsy syndrome	9e-05	0.000997	CcSEcCtD
Caffeine—Haemorrhage—Topiramate—epilepsy syndrome	8.95e-05	0.000992	CcSEcCtD
Caffeine—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.94e-05	0.000991	CcSEcCtD
Caffeine—Tachycardia—Valproic Acid—epilepsy syndrome	8.9e-05	0.000987	CcSEcCtD
Caffeine—CYP2E1—nervous system—epilepsy syndrome	8.89e-05	0.00191	CbGeAlD
Caffeine—Skin disorder—Valproic Acid—epilepsy syndrome	8.86e-05	0.000982	CcSEcCtD
Caffeine—Rash—Vigabatrin—epilepsy syndrome	8.78e-05	0.000974	CcSEcCtD
Caffeine—Dermatitis—Vigabatrin—epilepsy syndrome	8.78e-05	0.000973	CcSEcCtD
Caffeine—Convulsion—Pregabalin—epilepsy syndrome	8.75e-05	0.00097	CcSEcCtD
Caffeine—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.75e-05	0.00097	CcSEcCtD
Caffeine—Hypertension—Pregabalin—epilepsy syndrome	8.72e-05	0.000967	CcSEcCtD
Caffeine—Rash—Diazepam—epilepsy syndrome	8.65e-05	0.000959	CcSEcCtD
Caffeine—Dermatitis—Diazepam—epilepsy syndrome	8.64e-05	0.000958	CcSEcCtD
Caffeine—ABCB1—telencephalon—epilepsy syndrome	8.58e-05	0.00184	CbGeAlD
Caffeine—CYP2E1—central nervous system—epilepsy syndrome	8.56e-05	0.00184	CbGeAlD
Caffeine—Agitation—Gabapentin—epilepsy syndrome	8.51e-05	0.000944	CcSEcCtD
Caffeine—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.45e-05	0.000937	CcSEcCtD
Caffeine—Rash—Felbamate—epilepsy syndrome	8.37e-05	0.000928	CcSEcCtD
Caffeine—CYP2E1—cerebellum—epilepsy syndrome	8.37e-05	0.0018	CbGeAlD
Caffeine—Dermatitis—Felbamate—epilepsy syndrome	8.36e-05	0.000927	CcSEcCtD
Caffeine—Cardiac disorder—Topiramate—epilepsy syndrome	8.31e-05	0.000921	CcSEcCtD
Caffeine—Rash—Zonisamide—epilepsy syndrome	8.19e-05	0.000908	CcSEcCtD
Caffeine—Infection—Pregabalin—epilepsy syndrome	8.19e-05	0.000908	CcSEcCtD
Caffeine—Dermatitis—Zonisamide—epilepsy syndrome	8.19e-05	0.000907	CcSEcCtD
Caffeine—Dyspnoea—Valproic Acid—epilepsy syndrome	8.13e-05	0.000901	CcSEcCtD
Caffeine—Immune system disorder—Topiramate—epilepsy syndrome	8.09e-05	0.000896	CcSEcCtD
Caffeine—Nervous system disorder—Pregabalin—epilepsy syndrome	8.08e-05	0.000896	CcSEcCtD
Caffeine—CYP2C8—brain—epilepsy syndrome	8.07e-05	0.00174	CbGeAlD
Caffeine—Tachycardia—Pregabalin—epilepsy syndrome	8.05e-05	0.000892	CcSEcCtD
Caffeine—Convulsion—Gabapentin—epilepsy syndrome	8.03e-05	0.00089	CcSEcCtD
Caffeine—Skin disorder—Pregabalin—epilepsy syndrome	8.01e-05	0.000888	CcSEcCtD
Caffeine—Hypertension—Gabapentin—epilepsy syndrome	8e-05	0.000886	CcSEcCtD
Caffeine—Rash—Clonazepam—epilepsy syndrome	7.9e-05	0.000875	CcSEcCtD
Caffeine—Dermatitis—Clonazepam—epilepsy syndrome	7.89e-05	0.000874	CcSEcCtD
Caffeine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.87e-05	0.000873	CcSEcCtD
Caffeine—Rash—Phenytoin—epilepsy syndrome	7.84e-05	0.000869	CcSEcCtD
Caffeine—Dermatitis—Phenytoin—epilepsy syndrome	7.84e-05	0.000869	CcSEcCtD
Caffeine—Rash—Oxcarbazepine—epilepsy syndrome	7.8e-05	0.000865	CcSEcCtD
Caffeine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.79e-05	0.000864	CcSEcCtD
Caffeine—Malnutrition—Topiramate—epilepsy syndrome	7.79e-05	0.000864	CcSEcCtD
Caffeine—Nervousness—Topiramate—epilepsy syndrome	7.57e-05	0.000839	CcSEcCtD
Caffeine—Infection—Gabapentin—epilepsy syndrome	7.51e-05	0.000833	CcSEcCtD
Caffeine—Rash—Carbamazepine—epilepsy syndrome	7.49e-05	0.00083	CcSEcCtD
Caffeine—Dermatitis—Carbamazepine—epilepsy syndrome	7.48e-05	0.000829	CcSEcCtD
Caffeine—CYP1A1—brain—epilepsy syndrome	7.45e-05	0.0016	CbGeAlD
Caffeine—CYP2D6—head—epilepsy syndrome	7.43e-05	0.0016	CbGeAlD
Caffeine—Nervous system disorder—Gabapentin—epilepsy syndrome	7.41e-05	0.000822	CcSEcCtD
Caffeine—Tachycardia—Gabapentin—epilepsy syndrome	7.38e-05	0.000818	CcSEcCtD
Caffeine—Dyspnoea—Pregabalin—epilepsy syndrome	7.35e-05	0.000815	CcSEcCtD
Caffeine—Skin disorder—Gabapentin—epilepsy syndrome	7.34e-05	0.000814	CcSEcCtD
Caffeine—Rash—Lamotrigine—epilepsy syndrome	7.24e-05	0.000802	CcSEcCtD
Caffeine—Dermatitis—Lamotrigine—epilepsy syndrome	7.23e-05	0.000801	CcSEcCtD
Caffeine—Agitation—Topiramate—epilepsy syndrome	7.16e-05	0.000794	CcSEcCtD
Caffeine—CYP3A4—nervous system—epilepsy syndrome	7.15e-05	0.00154	CbGeAlD
Caffeine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.12e-05	0.000789	CcSEcCtD
Caffeine—CYP2D6—nervous system—epilepsy syndrome	7.04e-05	0.00151	CbGeAlD
Caffeine—CYP3A4—central nervous system—epilepsy syndrome	6.89e-05	0.00148	CbGeAlD
Caffeine—CYP2E1—brain—epilepsy syndrome	6.8e-05	0.00146	CbGeAlD
Caffeine—CYP2D6—central nervous system—epilepsy syndrome	6.78e-05	0.00146	CbGeAlD
Caffeine—Convulsion—Topiramate—epilepsy syndrome	6.75e-05	0.000748	CcSEcCtD
Caffeine—ABCB1—medulla oblongata—epilepsy syndrome	6.74e-05	0.00145	CbGeAlD
Caffeine—Dyspnoea—Gabapentin—epilepsy syndrome	6.74e-05	0.000747	CcSEcCtD
Caffeine—Hypertension—Topiramate—epilepsy syndrome	6.73e-05	0.000746	CcSEcCtD
Caffeine—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.72e-05	0.000745	CcSEcCtD
Caffeine—CYP2D6—cerebellum—epilepsy syndrome	6.62e-05	0.00142	CbGeAlD
Caffeine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.53e-05	0.000723	CcSEcCtD
Caffeine—Infection—Topiramate—epilepsy syndrome	6.32e-05	0.0007	CcSEcCtD
Caffeine—Nervous system disorder—Topiramate—epilepsy syndrome	6.24e-05	0.000691	CcSEcCtD
Caffeine—Tachycardia—Topiramate—epilepsy syndrome	6.21e-05	0.000688	CcSEcCtD
Caffeine—Skin disorder—Topiramate—epilepsy syndrome	6.18e-05	0.000685	CcSEcCtD
Caffeine—ABCB1—midbrain—epilepsy syndrome	6.16e-05	0.00132	CbGeAlD
Caffeine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.07e-05	0.000673	CcSEcCtD
Caffeine—ABCB1—spinal cord—epilepsy syndrome	6.01e-05	0.00129	CbGeAlD
Caffeine—Rash—Valproic Acid—epilepsy syndrome	5.75e-05	0.000637	CcSEcCtD
Caffeine—Dermatitis—Valproic Acid—epilepsy syndrome	5.74e-05	0.000637	CcSEcCtD
Caffeine—Dyspnoea—Topiramate—epilepsy syndrome	5.67e-05	0.000629	CcSEcCtD
Caffeine—Hypersensitivity—Gabapentin—epilepsy syndrome	5.57e-05	0.000617	CcSEcCtD
Caffeine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.49e-05	0.000609	CcSEcCtD
Caffeine—CYP2D6—brain—epilepsy syndrome	5.38e-05	0.00116	CbGeAlD
Caffeine—ABCB1—head—epilepsy syndrome	5.34e-05	0.00115	CbGeAlD
Caffeine—Rash—Pregabalin—epilepsy syndrome	5.2e-05	0.000576	CcSEcCtD
Caffeine—Dermatitis—Pregabalin—epilepsy syndrome	5.19e-05	0.000576	CcSEcCtD
Caffeine—ABCB1—nervous system—epilepsy syndrome	5.06e-05	0.00109	CbGeAlD
Caffeine—ABCB1—central nervous system—epilepsy syndrome	4.88e-05	0.00105	CbGeAlD
Caffeine—Rash—Gabapentin—epilepsy syndrome	4.77e-05	0.000528	CcSEcCtD
Caffeine—ABCB1—cerebellum—epilepsy syndrome	4.77e-05	0.00102	CbGeAlD
Caffeine—Dermatitis—Gabapentin—epilepsy syndrome	4.76e-05	0.000528	CcSEcCtD
Caffeine—Hypersensitivity—Topiramate—epilepsy syndrome	4.69e-05	0.000519	CcSEcCtD
Caffeine—Rash—Topiramate—epilepsy syndrome	4.01e-05	0.000445	CcSEcCtD
Caffeine—Dermatitis—Topiramate—epilepsy syndrome	4.01e-05	0.000444	CcSEcCtD
Caffeine—ABCB1—brain—epilepsy syndrome	3.87e-05	0.000832	CbGeAlD
Caffeine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.34e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.34e-06	1.21e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.33e-06	1.21e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GPX1—epilepsy syndrome	1.33e-06	1.21e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MTOR—epilepsy syndrome	1.33e-06	1.2e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	1.32e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.31e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.31e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.31e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.31e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	1.31e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.3e-06	1.18e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—AKT1—epilepsy syndrome	1.3e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	1.3e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—BCHE—epilepsy syndrome	1.3e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.3e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TH—epilepsy syndrome	1.3e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AGT—epilepsy syndrome	1.3e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TH—epilepsy syndrome	1.29e-06	1.17e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	1.29e-06	1.17e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RELA—epilepsy syndrome	1.28e-06	1.16e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SRC—epilepsy syndrome	1.28e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—APOE—epilepsy syndrome	1.27e-06	1.15e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SRC—epilepsy syndrome	1.27e-06	1.15e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.26e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.26e-06	1.14e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MTOR—epilepsy syndrome	1.26e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.26e-06	1.14e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.25e-06	1.13e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.25e-06	1.13e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.25e-06	1.13e-05	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.25e-06	1.13e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—epilepsy syndrome	1.25e-06	1.13e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	1.12e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CASP3—epilepsy syndrome	1.24e-06	1.12e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.24e-06	1.12e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.23e-06	1.12e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—AKT1—epilepsy syndrome	1.23e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.23e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.23e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.23e-06	1.11e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CASP3—epilepsy syndrome	1.22e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.22e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TH—epilepsy syndrome	1.22e-06	1.11e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.22e-06	1.11e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.21e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.2e-06	1.09e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—JUN—epilepsy syndrome	1.2e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.2e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.2e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.19e-06	1.08e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—JUN—epilepsy syndrome	1.19e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.18e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.17e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.17e-06	1.06e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MMP9—epilepsy syndrome	1.17e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.17e-06	1.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—AKT1—epilepsy syndrome	1.17e-06	1.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CASP3—epilepsy syndrome	1.16e-06	1.05e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.16e-06	1.05e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MMP9—epilepsy syndrome	1.16e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.15e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.15e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.15e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.14e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.14e-06	1.03e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.14e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.14e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.14e-06	1.03e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—epilepsy syndrome	1.14e-06	1.03e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—epilepsy syndrome	1.13e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.13e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.13e-06	1.02e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.12e-06	1.02e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—JUN—epilepsy syndrome	1.12e-06	1.02e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—epilepsy syndrome	1.12e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TH—epilepsy syndrome	1.12e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.12e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.1e-06	9.99e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.1e-06	9.91e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP9—epilepsy syndrome	1.09e-06	9.9e-06	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—epilepsy syndrome	1.09e-06	9.88e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—POMC—epilepsy syndrome	1.09e-06	9.87e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.08e-06	9.79e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.08e-06	9.77e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.08e-06	9.76e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SRC—epilepsy syndrome	1.08e-06	9.76e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.07e-06	9.66e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SRC—epilepsy syndrome	1.07e-06	9.64e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.07e-06	9.64e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—epilepsy syndrome	1.06e-06	9.6e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	1.06e-06	9.59e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—epilepsy syndrome	1.05e-06	9.51e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.05e-06	9.48e-06	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.04e-06	9.45e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.04e-06	9.44e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.04e-06	9.4e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.04e-06	9.4e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.04e-06	9.4e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—epilepsy syndrome	1.04e-06	9.39e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.04e-06	9.38e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.03e-06	9.29e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.02e-06	9.26e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	9.23e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SRC—epilepsy syndrome	1.01e-06	9.13e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.01e-06	9.11e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1e-06	9.05e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ALB—epilepsy syndrome	9.95e-07	9e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	9.91e-07	8.97e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—POMC—epilepsy syndrome	9.84e-07	8.9e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	9.83e-07	8.89e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—epilepsy syndrome	9.82e-07	8.89e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	9.8e-07	8.87e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	9.79e-07	8.86e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	9.79e-07	8.86e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TH—epilepsy syndrome	9.76e-07	8.84e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	9.75e-07	8.82e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	9.74e-07	8.82e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	9.7e-07	8.78e-06	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—epilepsy syndrome	9.7e-07	8.78e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	9.69e-07	8.77e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	9.66e-07	8.74e-06	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.65e-07	8.73e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	9.64e-07	8.72e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.62e-07	8.71e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	9.56e-07	8.65e-06	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—epilepsy syndrome	9.51e-07	8.61e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.47e-07	8.57e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.47e-07	8.57e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	9.35e-07	8.47e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.33e-07	8.45e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	9.28e-07	8.4e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	9.25e-07	8.38e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.23e-07	8.36e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAT—epilepsy syndrome	9.23e-07	8.35e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TH—epilepsy syndrome	9.2e-07	8.33e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	9.15e-07	8.28e-06	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—epilepsy syndrome	9.13e-07	8.26e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TH—epilepsy syndrome	9.12e-07	8.26e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GPX1—epilepsy syndrome	9.1e-07	8.24e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	9.03e-07	8.17e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.98e-07	8.13e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	8.98e-07	8.13e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ALB—epilepsy syndrome	8.97e-07	8.12e-06	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—epilepsy syndrome	8.95e-07	8.1e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.77e-07	7.94e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	8.76e-07	7.93e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	8.74e-07	7.91e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	8.7e-07	7.88e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AGT—epilepsy syndrome	8.47e-07	7.66e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AGT—epilepsy syndrome	8.45e-07	7.65e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	8.35e-07	7.55e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	8.33e-07	7.54e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	8.32e-07	7.53e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—APOE—epilepsy syndrome	8.3e-07	7.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	8.29e-07	7.5e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—APOE—epilepsy syndrome	8.28e-07	7.49e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	8.15e-07	7.38e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	8.11e-07	7.34e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAT—epilepsy syndrome	8.04e-07	7.28e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AGT—epilepsy syndrome	7.98e-07	7.22e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—epilepsy syndrome	7.95e-07	7.2e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.91e-07	7.16e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—epilepsy syndrome	7.88e-07	7.13e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	7.85e-07	7.1e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.82e-07	7.08e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—APOE—epilepsy syndrome	7.82e-07	7.08e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TH—epilepsy syndrome	7.79e-07	7.05e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.72e-07	6.99e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.68e-07	6.95e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.67e-07	6.94e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	7.61e-07	6.89e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.58e-07	6.86e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.52e-07	6.81e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAT—epilepsy syndrome	7.51e-07	6.8e-06	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—epilepsy syndrome	7.5e-07	6.79e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.48e-07	6.77e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.37e-07	6.67e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AGT—epilepsy syndrome	7.32e-07	6.62e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	7.31e-07	6.61e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GPX1—epilepsy syndrome	7.27e-07	6.58e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—APOE—epilepsy syndrome	7.17e-07	6.49e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—POMC—epilepsy syndrome	7.13e-07	6.45e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—POMC—epilepsy syndrome	7.11e-07	6.44e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.85e-07	6.2e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	6.79e-07	6.15e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.75e-07	6.11e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—POMC—epilepsy syndrome	6.72e-07	6.08e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—epilepsy syndrome	6.7e-07	6.07e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—epilepsy syndrome	6.62e-07	5.99e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	6.5e-07	5.89e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—epilepsy syndrome	6.5e-07	5.88e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—epilepsy syndrome	6.48e-07	5.87e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.42e-07	5.81e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAT—epilepsy syndrome	6.42e-07	5.81e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.4e-07	5.79e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AGT—epilepsy syndrome	6.38e-07	5.77e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—epilepsy syndrome	6.27e-07	5.67e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—APOE—epilepsy syndrome	6.25e-07	5.65e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	6.24e-07	5.65e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—POMC—epilepsy syndrome	6.16e-07	5.58e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—epilepsy syndrome	6.13e-07	5.54e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.1e-07	5.52e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.04e-07	5.46e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TH—epilepsy syndrome	6.02e-07	5.44e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.01e-07	5.44e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.96e-07	5.39e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.89e-07	5.33e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.84e-07	5.28e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.8e-07	5.25e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	5.68e-07	5.14e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	5.67e-07	5.13e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—epilepsy syndrome	5.62e-07	5.08e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—POMC—epilepsy syndrome	5.37e-07	4.86e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	5.36e-07	4.85e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	5.17e-07	4.68e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AGT—epilepsy syndrome	5.09e-07	4.61e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.06e-07	4.58e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.02e-07	4.54e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—POMC—epilepsy syndrome	5.01e-07	4.54e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.99e-07	4.51e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.95e-07	4.48e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	4.91e-07	4.45e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—epilepsy syndrome	4.89e-07	4.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.82e-07	4.36e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.61e-07	4.17e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.57e-07	4.14e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.48e-07	4.05e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—epilepsy syndrome	4.37e-07	3.96e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.28e-07	3.88e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.28e-07	3.87e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.03e-07	3.65e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	4e-07	3.62e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	3.94e-07	3.57e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.93e-07	3.56e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.91e-07	3.54e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.85e-07	3.48e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.42e-07	3.09e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.31e-07	2.99e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.01e-07	2.73e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	2.86e-07	2.59e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2.85e-07	2.58e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—epilepsy syndrome	2.69e-07	2.44e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.64e-07	2.39e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	2.47e-07	2.24e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.15e-07	1.95e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.03e-07	1.83e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.01e-07	1.82e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.72e-07	1.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.33e-07	1.2e-06	CbGpPWpGaD
